Restless legs syndrome as side effect of second generation antidepressants
- PMID: 18468624
- DOI: 10.1016/j.jpsychires.2008.02.006
Restless legs syndrome as side effect of second generation antidepressants
Abstract
Although of clinical interest, the question is still not fully answered whether antidepressants (AD) can cause or exacerbate restless legs syndrome (RLS). The literature provides contradictory information. This study addresses this problem for the class of second generation AD. In four neurological offices, all patients treated for the first time with an AD were prospectively observed with regard to the question of whether RLS occurred or pre-existing RLS worsened as a result of the medication. Because initial treatment in the participating offices is mainly executed with "modern" selective AD, the study was restricted to these drugs (fluoxetine, paroxetine, citalopram, sertraline, escitalopram, venlafaxine, duloxetine, reboxetine, and mirtazapine). In 9% of patients, RLS was recorded as a side effect related to the administration of AD. The frequency of this side effect varied among the drugs. The problem is most pronounced with mirtazapine provoking or deteriorating RLS in 28% of patients. By contrast, no case occurred during use of reboxetine. As for the other AD, the rate of newly occurred and deteriorated RLS, ranged from 5% to 10%. Typically, RLS occurred during the initial days of treatment.
Similar articles
-
Restless legs syndrome induced by escitalopram: case report and review of the literature.Pharmacotherapy. 2008 Feb;28(2):271-80. doi: 10.1592/phco.28.2.271. Pharmacotherapy. 2008. PMID: 18225972 Review.
-
Reboxetine adjunct for partial or nonresponders to antidepressant treatment.J Affect Disord. 2004 Jul;81(1):67-72. doi: 10.1016/j.jad.2003.08.001. J Affect Disord. 2004. PMID: 15183602 Clinical Trial.
-
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline.J Clin Psychiatry. 2006 Feb;67(2):325-6. doi: 10.4088/jcp.v67n0222c. J Clin Psychiatry. 2006. PMID: 16566633 No abstract available.
-
Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.Can J Psychiatry. 2005 Nov;50(13):877; author reply 877-8. doi: 10.1177/070674370505001320. Can J Psychiatry. 2005. PMID: 16483124 No abstract available.
-
Mirtazapine versus selective serotonin reuptake inhibitors.J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. J Clin Psychiatry. 1999. PMID: 10446737 Review.
Cited by
-
Suspected duloxetine-induced restless legs syndrome phenotypic variant: a case report.BMC Psychiatry. 2024 May 10;24(1):349. doi: 10.1186/s12888-024-05763-7. BMC Psychiatry. 2024. PMID: 38730422 Free PMC article.
-
Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study.PLoS One. 2019 Aug 1;14(8):e0220641. doi: 10.1371/journal.pone.0220641. eCollection 2019. PLoS One. 2019. PMID: 31369638 Free PMC article.
-
Consensus guidelines on the construct validity of rodent models of restless legs syndrome.Dis Model Mech. 2022 Aug 1;15(8):dmm049615. doi: 10.1242/dmm.049615. Epub 2022 Aug 10. Dis Model Mech. 2022. PMID: 35946581 Free PMC article.
-
Insomnia in hospitalized psychiatric patients: prevalence and associated factors.Neuropsychiatr Dis Treat. 2018 Apr 10;14:969-975. doi: 10.2147/NDT.S160742. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29695907 Free PMC article.
-
Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life.Diabetes Care. 2012 Dec;35(12):2451-8. doi: 10.2337/dc12-0656. Epub 2012 Sep 18. Diabetes Care. 2012. PMID: 22991449 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials